Today: 19 June 2026
Broadcom’s $2 Trillion AI Call Gets 7.5% Test Next Week

Broadcom’s $2 Trillion AI Call Gets 7.5% Test Next Week

NEW YORK, May 27, 2026, 11:02 EDT

  • Options pricing is signaling Broadcom shares could move about 7.5% when the company reports next week.
  • Investors are looking at rapid AI-chip growth but also asking if custom chips can deliver Nvidia-like margins.
  • Broadcom slipped in early U.S. trading but stayed above the $2 trillion mark on market value.

Broadcom (AVGO) options imply the stock could move around 7.5% in either direction following its quarterly earnings, due after the close on June 3, Bloomberg data shows. That sets up next week’s results as a key moment for one of the market’s top AI names.

Broadcom is shifting from a reputation as a broad chip and software maker to one focused on custom AI silicon. Its market cap stood at about $2.04 trillion Wednesday. Shares were off about 0.5% to $419.70 in the morning. Nvidia dropped 2.3% and Marvell fell 2.8%, putting pressure on AI chip stocks.

Broadcom is set to release its fiscal Q2 2026 numbers and outlook after the bell on June 3, the company said. Management will hold a call with analysts at 5 p.m. ET.

The Broadcom stock story isn’t just about demand now. The new debate is if Broadcom’s custom accelerators, designed for individual clients instead of sold as standard chips, can grow quickly enough without cutting into margins.

Broadcom reported in March that first-quarter revenue climbed 29% to $19.31 billion. The company guided for second-quarter revenue of around $22 billion, which would be a 47% jump from the same period last year. CEO Hock Tan said AI revenue growth was “accelerating” and forecast $10.7 billion in AI semiconductor revenue for the second quarter. Broadcom Inc.

Volatility is back in focus. According to Investing.com, which cited Bloomberg options data, Broadcom stock has swung more than options markets implied in half of its last eight earnings reports. The outsized moves have gone both up and down: shares jumped 31.8% in December 2024 and 26.2% in June 2024, but they also fell 13.4% in September 2024 and dropped 8.4% in March 2025.

Broadcom is pitching itself to customers looking for something other than Nvidia’s general-purpose GPUs, which have dominated AI training and inference. Back in March, Reuters said that Big Tech’s AI infrastructure spending could go over $600 billion this year, boosting demand for chips, servers, storage, and networking gear.

Marvell is getting drawn into the custom-chip battle. The Register reported Wednesday that IP firms like Broadcom and Marvell have built big chunks of custom AI silicon for hyperscale data centers. A lot of this activity hasn’t been public until now.

Broadcom (AVGO) is teaming up with FuriosaAI on a third-generation AI accelerator for inference, the companies said Wednesday. The chip will be built with a 2-nanometer compute die, HBM4/4E memory, plus Ethernet and PCIe tech from Broadcom. Sampling should begin in the first half of 2028.

Broadcom’s Semiconductor Solutions Group president Charlie Kawwas said inference now depends more on “data reuse and communication efficiency” across servers and racks. Furiosa co-founder and CEO June Paik called the deal a step past the chip level, saying it brings the product into the “token factory era.” Stock Titan

But the main risk is margin, not just sales. Barchart columnist Mikhail Fedorov wrote that custom AI chips are a different business than Nvidia’s GPU model, since the end chip is usually owned by the customer, with Broadcom handling architecture, IP, and supply chain work. In this arrangement, the customer is focused on cutting infrastructure costs, which he said could keep a lid on Broadcom’s profits as custom silicon accounts for a bigger part of revenue.

Broadcom’s bigger software business, boosted by VMware, acts as a buffer few chip-focused rivals have. For the first quarter, infrastructure software brought in $6.80 billion, or 35% of Broadcom’s revenue, with semiconductor solutions at $12.52 billion, about 65%. CFO Kirsten Spears said adjusted EBITDA reached 68% of sales and kept the forecast for that margin in the second quarter.

June 3 is now set up as the key test for whether investors see real earnings leverage or just more AI hype. The stock doesn’t need a flawless report, but at a $2 trillion valuation and options ready for a big swing, Wall Street wants specifics on AI revenue, margins, supply, and customer mix.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Tenon Medical Shares Plunge 42% Amid Nasdaq Compliance Concerns
    June 18, 2026, 7:39 PM EDT. Tenon Medical Inc. shares plunged 41.9% to $0.35 on Thursday, hitting a new 52-week low with trading volume surging over 360 times the average. The company faces Nasdaq compliance issues due to stock price falling below $1 and stockholders' equity under minimum required levels. Nasdaq gave Tenon until July 6 to submit a plan after equity dropped to $1.895 million against a $2.5 million minimum. Tenon also proposes a reverse stock split to boost share price ahead of a July 23 shareholder vote. Despite first-quarter revenue growth of about 90%, the firm's financials show a worsening deficit and a going-concern warning. The selloff contrasted with gains in broader markets and peers, signaling investor concerns about Tenon's liquidity and regulatory risks.

Latest articles

Cisco trades higher ahead of Juneteenth holiday with AI-networking names in the mix

Cisco trades higher ahead of Juneteenth holiday with AI-networking names in the mix

19 June 2026
Cisco surged 1.88% to $119.54 on heavy volume, snapping a four-day slide as investors bet on its raised $9 billion AI-infrastructure order target from hyperscale customers, but risks remain if AI demand slows or revenue conversion lags, especially with U.S. markets closed Friday for Juneteenth and after recent restructuring news.
Rocket Lab Drops Even After Nasdaq-100 Nod, SpaceX IPO Buzz Fades

Rocket Lab stock slips as Nasdaq-100 entry nears and SpaceX fever cools

19 June 2026
Rocket Lab fell 0.7% to $107.24 in heavy trading as investors weighed its upcoming Nasdaq-100 inclusion Monday against pressure from SpaceX’s post-IPO drop; despite a 63.5% revenue jump and KeyBanc’s upgrade, Rocket Lab posted a $45 million Q1 loss and faces risks tied to Neutron’s development.
Soligenix Stock Nearly Doubles Before the Bell as Ebola Vaccine Hopes Put Tiny Biotech Back in Play
Previous Story

Soligenix Stock Nearly Doubles Before the Bell as Ebola Vaccine Hopes Put Tiny Biotech Back in Play

Boston Scientific Hits Two-Year Low After Watchman Device Warning
Next Story

Boston Scientific Hits Two-Year Low After Watchman Device Warning

Go toTop